Hiroyuki Matsuno Selected Research

monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrate

6/2002

Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Matsuno Research Topics

Disease

7	Thrombosis (Thrombus) 01/2006 - 01/2002
4	Vascular System Injuries 01/2006 - 11/2003
3	Fibrosis (Cirrhosis) 02/2013 - 12/2008
3	Myocardial Infarction 01/2006 - 10/2002
2	Sandhoff Disease (Sandhoff's Disease) 01/2011 - 06/2009
2	Hypercholesterolemia 08/2006 - 07/2004
2	Heart Failure 01/2006 - 10/2002
2	Pathologic Constriction (Stenosis) 01/2006 - 07/2004
2	Ganglion Cysts (Ganglion) 10/2004 - 10/2002
2	Ischemia 10/2004 - 10/2002
2	Venous Thrombosis (Deep-Vein Thrombosis) 06/2002 - 01/2002
1	Cognitive Dysfunction 01/2016
1	Bone Diseases (Bone Disease) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2010
1	Albuminuria 11/2009
1	Pulmonary Edema 01/2006
1	Atherosclerotic Plaque (Atheroma) 01/2006
1	Atherosclerosis 01/2006
1	Neointima 07/2004
1	Vascular Remodeling 07/2004
1	Vascular Diseases (Vascular Disease) 03/2004
1	Hemorrhage 07/2003
1	Pulmonary Embolism 07/2003
1	Hypothermia 10/2002
1	Sudden Death 10/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2002
1	Pulmonary Heart Disease (Cor Pulmonale) 10/2002
1	Infarction (Infarctions) 10/2002
1	Carotid Artery Thrombosis 06/2002
1	Osteoporosis 01/2002

Drug/Important Bio-Agent (IBA)

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 10/2002
4	Fibrinolysin FDA Link 01/2006 - 01/2002
3	Plasminogen Activator Inhibitor 1IBA 07/2003 - 02/2002
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2013 - 01/2010
2	G(M2) Ganglioside (Ganglioside GM2)IBA 01/2011 - 06/2009
2	OligosaccharidesIBA 01/2011 - 06/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2010 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 12/2008 - 07/2004
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 03/2004
2	PlasminogenIBA 01/2006 - 01/2002
2	Crystallins (Crystallin)IBA 01/2006 - 06/2005
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2005 - 01/2002
2	Retinaldehyde (Retinal)IBA 10/2004 - 10/2002
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Phospholipases (Phospholipase)IBA 02/2013
1	CalciumIBA 02/2013
1	Lipase (Acid Lipase)FDA Link 02/2013
1	ProstaglandinsIBA 02/2013
1	Prostaglandins FIBA 02/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2013
1	Calcium-Independent Phospholipases A2IBA 02/2013
1	ChemokinesIBA 01/2011
1	Dinoprostone (PGE2)FDA Link 01/2011
1	Hexosaminidases (Hexosaminidase)IBA 01/2011
1	Adenosine Diphosphate (ADP)IBA 11/2009
1	AcetylglucosamineIBA 06/2009
1	beta-N-AcetylhexosaminidasesIBA 06/2009
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 08/2006
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 08/2006
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2006
1	activin AIBA 01/2006
1	CollagenIBA 01/2006
1	CoagulantsIBA 01/2006
1	AnticoagulantsIBA 01/2006
1	LipidsIBA 01/2006
1	Becaplermin (PDGF-BB)FDA Link 06/2005
1	p38 Mitogen-Activated Protein KinasesIBA 06/2005
1	Platelet-Derived Growth FactorIBA 06/2005
1	platelet-derived growth factor AIBA 06/2005
1	MitogensIBA 06/2005
1	Glutamic Acid (Glutamate)FDA Link 10/2004
1	NeurotoxinsIBA 10/2004
1	Kainic Acid (Kainate)IBA 10/2004
1	N-Methylaspartate (NMDA)IBA 10/2004
1	Matrix Metalloproteinase InhibitorsIBA 07/2004
1	N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA 07/2004
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	Simvastatin (Zocor)FDA LinkGeneric 03/2004
1	(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA 07/2003
1	Heparin (Liquaemin)FDA LinkGeneric 07/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2003
1	Factor Xa InhibitorsIBA 07/2003
1	Factor Xa (Coagulation Factor Xa)IBA 07/2003
1	alpha-Crystallin B ChainIBA 01/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2002
1	monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrateIBA 06/2002
1	Thrombin FDA Link 06/2002
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2002
1	GlucocorticoidsIBA 01/2002

Therapy/Procedure

6	Therapeutics 03/2011 - 01/2002
1	Lasers (Laser) 11/2009
1	Intravitreal Injections 10/2004
1	Oral Administration 06/2002